The Effect of Integrated Leading, Managing and Governing for Result Model Towards Institutional Delivery

June 4, 2019 updated by: Yeshambel Agumas Ambelie, Bahir Dar University

The Effect of Integrated Health System Leading, Managing and Governing for Result Model Towards Institutional Delivery Among Staff of Health Facilities in Northwest Ethiopia

The need for leading people, managing work, and governing organizations never changed over the civilization paths of society. However, people in every pole of the globe observe: over-led and under-managed, over-managed and under-governed, and even out of these organizations. These disparities have remained worse in the health system of developing countries like Ethiopia.

To date, Ethiopia put a goal of ending preventable child and maternal death, in achieving universal healthcare by 2035. Nevertheless, the investment on integrated leadership, management and governance is limited.

Therefore, this study hypothesize that institutional delivery are expressively linked with integrated health system leading, managing and governing for results model among health facilities staff in northwest Ethiopia?

Study Overview

Detailed Description

The investment on integrated health system leading, managing and governing for result model narrow down health system gaps.

The need to integrate these three distinct, but not hostile paths is that mostly: leading is people oriented process, managing is task oriented process and governing is organization oriented path.

Moreover, these paths are reflected even in a single person, task, or organization. Thus, testing and implementing integrated model is cost effective.

Study Type

Interventional

Enrollment (Actual)

418

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Amhara
      • Liben, Amhara, Ethiopia, 1000
        • North Achefer district

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All staff nominated by the respective districts that have been selected, but not deployed yet, for integrated health system leadership, management and governance for intervention by Amhara regional health office in the study setting have been included.

Exclusion Criteria:

  • No exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Staff of facilities for intervention
Intervention: Participants have been trained two times in six months period with integrated leading, managing and governing for results model.
Integrated leading, managing and governing for results model is an intervention launched to improve institutional delivery.
Active Comparator: Staff of facilities for control
Intervention: Participants have been trained two times in six months period with traditional model.
Traditional model is a health service delivery model already in place in the government health system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Institutional delivery
Time Frame: Up to six months
Increased institutional delivery. These have been assessed by institutional delivery follow up checklist. To declare that integrated leading, managing and governing for result model has an effect on institutional delivery improvement, on which it could be increased at least by 15%.
Up to six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Habit of institutional delivery
Time Frame: two weeks
Improvement on habit of institutional delivery has been explored from key informants, by key informant guideline. The explored data will be analyzed thematically, using the Qualitative Data Analysis (QDA) miner 4 software.
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: G D Alene, PhD, Bahir Dar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2018

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

October 30, 2018

Study Registration Dates

First Submitted

July 9, 2018

First Submitted That Met QC Criteria

August 17, 2018

First Posted (Actual)

August 21, 2018

Study Record Updates

Last Update Posted (Actual)

June 6, 2019

Last Update Submitted That Met QC Criteria

June 4, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 090/18-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The IPD will be shared up on the intervention study report has been published.

IPD Sharing Time Frame

From October 2019 to June 2020

IPD Sharing Access Criteria

For any humanistic purposes

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Leadership

3
Subscribe